Cas 479690-19-2,Benzenamine, 4-[[7-(2-bromoethoxy)-6-methoxy-4-quinolinyl]oxy]-3-fluoro-

479690-19-2

Post Buying Request

Basic information

Product Name: Benzenamine, 4-[[7-(2-bromoethoxy)-6-methoxy-4-quinolinyl]oxy]-3-fluoro-
Synonyms:
CAS NO:479690-19-2
Molecular Formula: C18H16BrFN2O3
Molecular Weight: 407.239
EINECS: N/A
Product Categories: N/A
Mol File: 479690-19-2.mol

Chemical Properties

Melting Point: N/A
Boiling Point: N/A
Flash Point: N/A
Appearance: N/A
Density: N/A
Refractive Index: N/A
Storage Temp.: N/A
Solubility: N/A
CAS DataBase Reference: Benzenamine, 4-[[7-(2-bromoethoxy)-6-methoxy-4-quinolinyl]oxy]-3-fluoro-(CAS DataBase Reference)
NIST Chemistry Reference: Benzenamine, 4-[[7-(2-bromoethoxy)-6-methoxy-4-quinolinyl]oxy]-3-fluoro-(479690-19-2)
EPA Substance Registry System: Benzenamine, 4-[[7-(2-bromoethoxy)-6-methoxy-4-quinolinyl]oxy]-3-fluoro-(479690-19-2)

Safety Data

Hazard Codes: N/A
Statements: N/A
Safety Statements: N/A
WGK Germany:
RTECS:
HazardClass: N/A
PackingGroup: N/A
Hazardous Substances Data: 479690-19-2(Hazardous Substances Data)

Suppliers
Usage
Upstream product
Downstream Products
Article

479690-19-2 Suppliers

Recommended suppliers

479690-19-2 Usage

Check Digit Verification of cas no

The CAS Registry Mumber 479690-19-2 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 4,7,9,6,9 and 0 respectively; the second part has 2 digits, 1 and 9 respectively.
Calculate Digit Verification of CAS Registry Number 479690-19:
(8*4)+(7*7)+(6*9)+(5*6)+(4*9)+(3*0)+(2*1)+(1*9)=212
212 % 10 = 2
So 479690-19-2 is a valid CAS Registry Number.

479690-19-2Upstream product

479690-19-2Downstream Products

479690-19-2Relevant academic research and scientific papers

QUINOLINE DERIVATIVE AND QUINAZOLINE DERIVATIVE INHIBITING SELF?PHOSPHORYLATION OF HEPATOCYTUS PROLIFERATOR RECEPTOR, AND MEDICINAL COMPOSITION CONTAINING THE SAME

-

Page 101, (2008/06/13)

An objective of the present invention is to provide compounds having potent antitumor activity. The compounds of the present invention are represented by formula (I) or a pharmaceutically acceptable salt or solvate thereof: wherein X = CH or N; Z = O or S

Post a RFQ

Cas No.:

Product Name:

Quantity:

Email:

Company name:

Valid Period:

Detailed Requirements:

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

What can I do for you?
Get Best Price

Get Best Price for 479690-19-2